Flovent, Advair Black Box Warning Removal Sought By GSK In FDA Petition
Executive Summary
GlaxoSmithKline is asking FDA to remove the inhaled corticosteroid class "black box" warning on the grounds that physicians recognize the need to taper oral steroids before initiating therapy with inhaled products.